Gut Microbiota and Alzheimer Disease

Area of Science:

• Neuroscience
• Microbiology
• Gastroenterology

Background:

• Alzheimer's disease (AD) is characterized by brain dysfunction and amyloid/tau protein accumulation.
• Early detection of amyloid buildup is possible via imaging years before dementia onset.
• Projected increases in AD incidence necessitate urgent preventative and therapeutic strategies.

Purpose of the Study:

• To explore the potential role of the gut microbiota (GMB) in Alzheimer's disease (AD) development.
• To investigate the gut-brain-microbiota axis as a factor in AD pathogenesis.
• To review emerging therapeutic and preventative strategies targeting the GMB for AD.

Main Methods:

• Review of current scientific literature on the gut-brain-microbiota axis and AD.
• Analysis of studies investigating the influence of gut flora on AD pathology.
• Exploration of GMB modulation techniques as potential AD interventions.

Main Results:

• Emerging evidence suggests a significant link between gut microbiota composition and AD.
• The gut-brain-microbiota axis is increasingly recognized as a potential contributor to AD.
• Modifying the GMB through diet or interventions shows promise for AD management.

Conclusions:

• The gut microbiota represents a promising target for novel Alzheimer's disease therapies.
• Interventions aimed at modulating the gut-brain-microbiota axis could offer preventative or therapeutic benefits for AD.
• Further research into the microbiome-AD connection is crucial for developing effective strategies.